🇮🇳IN
Sign In
BP

BPLPHARMA

NSE

Bharat Parenterals Ltd

₹2,213.60

+65.10(+3.03%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

BPLPHARMA valuation summary

Bharat Parenterals Ltd trades at 123.0 times trailing earnings. Return on equity is 4.0% and return on capital employed is 5.8%. The dividend yield is 0.06%. That P/E equals an earnings yield of 0.8%. The median P/E across 102 listed Drug Manufacturers - Specialty & Generic companies is 35.6, so Bharat Parenterals Ltd trades at a 4041% premium to that median.

P/E123.0
ROE4.0%
ROCE5.8%
Dividend yield0.06%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer